The Crystal and Molecular Structure and Absolute Configuration of (—)-(\u3ci\u3eS\u3c/i\u3e)-Warfarin by Valente, Edward J. et al.
University of Portland
Pilot Scholars
Chemistry Faculty Publications and Presentations Chemistry
1975
The Crystal and Molecular Structure and Absolute
Configuration of (—)-(S)-Warfarin
Edward J. Valente
University of Portland, valentee@up.edu
W. F. Trager
L. H. Jensen
Follow this and additional works at: http://pilotscholars.up.edu/chm_facpubs
Part of the Medicinal-Pharmaceutical Chemistry Commons
This Journal Article is brought to you for free and open access by the Chemistry at Pilot Scholars. It has been accepted for inclusion in Chemistry
Faculty Publications and Presentations by an authorized administrator of Pilot Scholars. For more information, please contact library@up.edu.
Citation: Pilot Scholars Version (Modified MLA Style)
Valente, Edward J.; Trager, W. F.; and Jensen, L. H., "The Crystal and Molecular Structure and Absolute Configuration of (—)-(S)-
Warfarin" (1975). Chemistry Faculty Publications and Presentations. 5.
http://pilotscholars.up.edu/chm_facpubs/5
954 
Acta Cryst. (1975). 831, 954 
The Crystal and Molecular Structure and Absolute Configuration of (- )-(S)-Warfarin 
BY E.J.VALENTE, W.F.TRAGER AND L.H.JENSEN 
Departments of Chemistry, Pharmaceutical Science, and Biological Structure, Uni1:ersity of Washington, 
Seattle, Washington 98195, U.S.A. 
(Received 7 March 1974; accepted 7 November 1974) 
The crystal and molecular structure and the absolute configuration of ( - )-(S)-warfarin, C19H 160 4, 
have been determined by X-ray crystallographic techniques. Crystals of ( - )-(S)-warfarin are ortho-
rhombic, space group P21212i. with a= 10·883 (3), b= 9·562 (3), and c= 14·902 (5) A. Solution of the 
structure was by direct methods, and refinement by least-squares calculations led to a conventional R 
of 0·053 (Mo Ka. data). The molecule crystallizes as the intramolecular hemiketal and thus may be de-
scribed as (2S, 4S)-2,3H-2-methyl-4-phenyl-5-oxol;lenzopyrano[3,4-eJdihydropyran-2-ol. The absolute 
configuration was confirmed by recollecting with Cu Ka. radia tion a group of reflections predicted to 
have the greatest observable Bijvoet differences based on the anomalous scattering of oxygen and the 
parameters from the refinement with Mo Kr¥. data. A group of 51 Friedel pairs, 86 % of which indicate 
the S enantiomer, gave a 17% decrease in the residual over the R enantiomer. Refinement of the imagi-
nary part of the anomalous dispersion of oxygen gave a value of 0·037 for Af". 
Introduction 
Warfarin [3-(!X-acetonylbenzyl)-4-hydroxycoumarin, fa] 
is an extensively used rodenticide and clinically effec-










R2 = -H; 
R1= -OH; 
R,=-H; 
R, = -H; 
R1= -COCH1 
R1= -COCH3 
R1 = -CHOHCH, 
R1= -COCH3 
Considerable concern ha~ developed in recent years 
over the appearance of a resistant strain of rats in Scot-
land and their subsequent spread to Northern Europe 
(Jackson, 1969a, b; Bentley, 1969; Drummond, 1970) 
and the United States (Jackson, Spear & Wright, 
1971). At the clinical level, problems have arisen from 
use of the drug because of the variability in biologic 
response sometimes produced by the concomitant ad-
ministration of other medications (Koch-Weser & Sel-
lers, 1971). 
The drug exists in two enantiomeric forms and it is 
known that the (S) isomer is approximately five to six 
times as potent as the (R) isomer in both the rat (Eble, 
West & Link, 1966; Bewick, 1972; Breckenridge & 
Orme, 1972) and man (Hewick & McEwen, 1973), al-
though the clinically available form of the drug is the 
racemate. Recent evidence has demonstrated that in 
man, the two enantiomeric forms are metabolized dif-
ferently (Chan, Lewis & Trager, 1972; Lewis, Trager , 
Chan, Breckenridge, Orme, Roland & Shung, 1974). 
The (S) isomer is stereoselectively oxidized to the in-
active 7-hydroxywarfarin, (lb), while the (R) isomer i1 
stereospecifically reduced to the slightly active ( R,S) 
alcohol, (le). Both isomers are oxidized to the inactive! 
6-hydroxywarfarin, (Id). It has further been demon-! 
strated that prior administration of other drugs, e.g.! 
phenylbutazone, will quantitatively affect these meta-! 
bolic pathways to different degrees (Lewis et al. , 1973)' 
and as a consequence offer in part an explanation al 
the molecular level of the effects that are observed at 
the clinical level. Thus we felt that it was of some im· 
portance to establish the assignment of the absolute 
configuration of the warfarin iso mers by an indepell· 
dent means. 
Originally the assignment of ( - )-(S)-warfarin was 
derived by relating it to ( - )-(R)-/3-phenylcaproic acid 
through a series of reactions not involving the asym· 
metric center (West, Preis, Schroeder & Link, 196 I). We 
report here confirmation of the above assignment by 
the anomalous scattering of oxygen. 
Experimental 
Crystals of ( - )-warfarin, grown from acetone by slow 
evaporation of the solvent, are colorless elongated 
prisms, melting at 172·5-173 °C, and having [ani"" 
Table 1. Crystal data 
Crystal system 
Space group 
Cell dimensions (based on 
Mo Ka =0-71069 A) 
Unit-cell volume 
z 





a= 10·883 (3) A 
b = 9·562 (3) 
c = 14·902 (5) 
1550·8 A' 
4 
1·34 (l) g cm- • 
1·33gcm- 3 
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- 127·4 (2)\ 1·2 g/ 100 ml, 0·5 N NaOH. Crystal data 
are listed in Table 1. 
Intensity data were collected on a computer-con-
trolled four-circle diffractometer from a crystal meas-
uring 0·5 x 0·6 x 0·5 mm mounted along c. The (l)j2() 
~can technique was used at a scan speed of 2° min- • 
in 28. 20 s background counts were collected at each 
limit of the scan range which was varied to account 
for the a1-a2 separation. Five monitor reflections were 
collected at intervals of 200 reflections, and a decrease 
in intensi ty of I· 2 % was observed in collecting the 2564 
reflections to sin8/A.=0·70 A-• (excluding those sys-
tematically absent). 
A correction for coincidence loss was applied to the 
intense reflections, increasing the count of the most 
intense reflection (013) by 14·7 %. Although absorp-
tion is small, an empirical correction based on the 
variation in the intensity of the 002 as a function of 
q1 atx = 90° (range, 5· 5 % in /) was applied. 
Atom scattering factors for carbon and oxygen were 
from International Tables for X-ray Crystallogra· 
phy ( 1962) and the bonded form factors of Stewart, 
Davidson & Simpson (1965) for hydrogen were used. 
Determination of the structure and refinement 
The 200 £-values greater than l ·8 were used in the 
program MULTAN (Main, Woolfson & Germain, 
1971} to generate a starting set of phases (RK•r•• = 
21-42, absolute figure of merit== I ·01). An E map based 
on these phases showed what appeared to be the 
coumarin ring fragment. Further examination of the 
E map revealed the presence of yet another ring, fused 
to the coumarin at C(3) and C(4) (see Fig. J), a nd a 
region of electron density at a position significantly 
out of the plane roughly described by the coumarin 
rings. A plau sible model for part of the molecule could 
be inferred, however, and three cycles of structure fac-
fig. I . Thermal-ellipsoid plot of the structure of (- )-(S)-
warfarin and the numbering of the atoms. View in z direc-
tion. 
ACJJB - 2 
tor-Fourier synthesis revealed all the remaining heavy 
atoms. Three cycles of least-squares calculations with 
data limited to sin 0/A.=0·40 A- 1 converged to an 
R( = .LllFol-IF(!l/2:1FoD of0·28, but bond lengths were 
unreasonable, and it was apparent that the model was 
incorrect. 
Using the coumarin ring atoms in the a bove trial, 
we performed multiple Patterson superpositions, but 
were unable to deduce a satisfactory model. Accord· 
ingly, a second set of phases (RKar1.,=21·96, absolute 
figure of merit= I ·00) was tried, giving an E map with 
what appeared to be the coumarin r ing fragment in 
nearly the same position as the first set. A third start-
ing set (RKarlc = 22·02, absolute figure of merit= 0·95} 
gave an E map again revealing the coumarin ring and 
hemiketal portions of warfarin as before, but shifted 
by y= -0·44. A si ngle F0 synthesis revealed 18 of the 
23 non-hydrogen atoms, and a subsequent difference 
map showed the remaining fi ve. R at this point was 
0·31. 
With data to sint9/).=0·55 A- 1 (1265 reflections), 
two cycles of least-squares refinement on all non-hydro-
gen atoms with isotropic temperature factors reduced 
R to 0· 105. The data set was now expanded to include 
all the reflections to sin Bj}. =0· 70 A - 1, those with net 
negative counts being set to zero. Anisotropic tem-
perature factors were included in the next least-squares 
refinement, and R decreased to 0·092. A difference 
map was computed and 15 of the 16 hydrogen atoms 
were located. One cycle of block-diagonal least-squares 
refinement adjusting only the hydrogen atoms with 
isotropic thermal parameters (initially set to the value 
of the adjacent heavy atom} was carried out and a new 
difference map revealed the remaining hydrogen atom, 
H(31). At this point we appl ied a 2q threshold in F 
[equivalent to a threshold of o(/)) and introduced 
weights of l /a 2(F), unit weights having been used up 
to this point. Four final least-squares cycles (blocks 
of approximately 140 parameters in two passes for 
each cycle) led to convergence. The final R was 0·053 
for 2264 reflections to sin 8/ A.= O· 70 A - 1 with F greater 
than 2(j(F) and Rw[ = l!(z)vl1Fol -1Fci12/2:w1F0 l2)] was 
0-024 for the same data set. The average shift/error 
during the last cycle was O· 31 a for 272 parameters.* 
Final parameters are listed in Tables 2 and 3. 
Results and discussion 
The primary feature of the structure of ( - )-warfarin 
(Fig. 1) is the hemiketal ring formed by cyclization of 
the side-chain keto function and the phenolic hydroxyl 
in the 4 position of the coumarin ring system. The 
crystal structure of racemic warfarin (Bravic, Gaultier 
* A list of structure factors has been deposited with the 
British Library Lending Division as Supplementary Publica-
tion No. SUP 30769 (16 pp., l microfiche). Copies may be ob-
tained throush The Executive Secretary, International Union 
of Crystallography, 13 White Friars, Chestet C Hl lNZ, Eng-
land. 
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& Hauw, 1973) also displays the hemiketal ring feature. 
Moreover, an acetone-d6 n.m.r. spectrum of the re-
solved ( - )-warfarin (Porter, Trager & Valente, 1973) 
indicates that the hemiketal also exists in solution. An 
examination of the bond lengths within the hemiketal 
ring reveals that the atoms have retained some of the 
character expected for the open side chain (keto) com-
pound. The C(4)-0(4) bond length of 1 ·351 (2) A is 
close to a phenolic C-0 bond. Also, the bond lengths 
between C(12) and C(13) and between C(l3) and C(l4) 
are 1·504 (3) and 1'507 (3) A respectively, close to ex-
pected values for C-C bonds adjacent to carbonyl 
groups. 
Table 3. Parameters for hydrogen atoms with estimated 
standard deviations in parentheses 
Positional parameters x 10'; thermal parameters x 103 ; tem. 
pcrature-factor expression exp [-8n2 U 2(sin2 fJ/A.)f. 
A striking feature is the unusually long C-0 bond 
between C(13) and 0(4) of 1 ·483 (2) A. Examination 
of representative hemiketals such as are found in sor-
bose (Kim & Rosenstein, 1967), tagatose (Takagi & 
Rosenstein, 1969), and coriose (Taka, Osaki & Okuda, 
1970) show that bond lengths in the range 1 ·42-1 ·45 A 
are expected (see Table 4). The conformation of the 
hemiketal is affected by the near planarity of the 
coumarin ring system which maintains C(l l) and 0(4) 
in approximate coincidence with that plane. C(l2) 
alone is predominantly out of that plane, imparting 
the half-chair conformation to the hemiketal ring. 
Atoms C(2)-C(l l), 0(1), 0(2) and 0(4) have a stan-
dard deviation of 0·086 A from the least-squares plane 
through them. 0(2) and C(l l) are the farthest from 
the plane, deviating by +0·16 and -0·19 A respec-
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- 4443 (26) 
-4738 (25) 
-2972 (26) 
z /c u 
- 2562 (15) 111 ( l l) 
- 3644 (14) 69 (7) 
- 3503 (15) 98 (9) 
- 3192 (15) 79 (7) 
-3027 (16) 75 (8) 
-31 87(1 2) 48 (5) 
- 4206 (12) 52 (6) 
-4798 (14) 58 (6) 
-4737 ( 16) 81 (8) 
- 3738 (14) 75 (8) 
- 3973 (16) 91 (9) 
- 51 85 (14) 71 (7) 
- 6334 ( 18) 123 (10) 
-61 51 (17) 
- 5145 (16) 








Within the coumarin system, the length of the double 
bond C(3)-C(4), 1·351 (3) A, is reasonable for a C""C 
conjugated to a carbonyl, and the adjacent C(2)-C(J) 
bond of l ·439 A is shortened because of resonance. 
We have compared the bond lengths and angles of 
fig. 2. Projection illustrating hydrogen bonding between pairs 
of molecules related by the twofold screw axis parallel toy. 
Table 2. Parameters for non-hydrogen atoms with estimated standard deviations in parentheses 
Positional parameters x 105 ; thermal parameters x 104 ; temperature-factor expression exp [ - 2n 2( U11h2a •2 + .. . + 2 U23klb*c*)]. 
x/a y/b z/c U11 u,, UJ3 U12 u,3 Vi, 
0(1) 34532 (12) 7017 (15) -31554 (I 0) 401 (7) 652 (9) 611 (9) -26 (7) 100 (7) -55 (8) 
0(2) 25520 (12) -1 3441 (14) -30565 (9) 530 (8) 598 (8) 640 (9) 36 (8) - 8 (8) -136 (8) 
0(3) -11704 (13) 15937 (16) - 27673 (10) 647 (9) 659 (JO) 504 (8) 90 (9) - 149 (7) -96 (8) 
0(4) 1932 (11) 26738 (13) -37447 (9) 399 (7) 534 (8) 559 (8) 1 (7) - 7 (6) -38 (7) 
C(2) 24196 (18) -1146 (22) -32432 (13) 448 (11) 636 (13) 394 (11) - 6 (10) -16 (10) -14 (10) 
C(3) 12959 (16) 5307 (20) - 35398 (12) 392 (10) 510 (11) 369 (10) - 20 (10) 7 (8) 13 (9) 
C(4) 12311 (16) 19406 (20) -35816(12) 391 (10) 568 (12) 352 (IO) 2 (10) - 9 (9) -8 (9) 
C(5) 23296 (22) 42671 (25) -35321 (16) 550 (14) 588 (15) 565 (14) - 36 (13) - 51 (12) 87 (1 2) 
C(6) 34204 (25) 49960 (27) - 34337 (16) 668 (16) 646 (15) 616 (1 5) -1 74 (14) - 77 (13) l36 (13) 
C(7) 44944 (23) 42825 (30) -32523 (17) 575 (15) 820 (19) 576 (15) - 230 (15) - 32 (13) 105 (14) 
C(8) 44997 (21) 28544 (30) -31603 (1 6) 466 (14) 851 (1 9) 520 (14) - 105 (14) 54 (12) -12 (14) 
C(9) 34098 (19) 21302 (23) -32714 (14) 434 (12) 610 (14) 402 (1 1) - 65 (11) 63 (10) 35 (10 
C(IO) 23126 (17) 28103 (22) -34544 (13) 431 (1 1) 548 (13) 365 (11) - 39 (10) -30 (9) 60 (10) 
C(l l) 2059 (18) -399-0 (22) - 37456 (15) 41 6 (11) 540 (13) 457 (12) -52 (II) - 6 (10) - 40 (11) 
C(l2) -8128 (20) 5106 (24) -41 553 (17) 389 ( 12) 614 (14) 573 (14) - 37 (12) 58 (11) 45 (12) 
C(l3) -9705 (17) 18753 (21) -36673 (14) 370 (l l ) 612 (13) 486 (ll) -20 (10) - 23(10) - 67(10) 
C(l4) -19183 (24) 28317 (32) -40767 (20) 448 (14) 772 (19) 678 (18) 90 (14) 14 (13) - 77 (16) 
C(l5) 4879 (18) -15763 (22) -44013 (14) 431 (11) 500 (13) 526 (12) - · 24 (I I ) 64 (10) - 25 (JO) 
C( l 6) 12586 (21) -13841 (28) -51310 (15) 651 (15) 639 (15) 599 (14) 98 (14) - 63 (12) -92 (1 4) 
C( l 7) 14023 (25) -24248 (31) - 57735 (18) 73 1 (17) 827 (19) 645 (1 6) - 48 (16) 23 (l 5) -179 (16J 
C( l8) 7823 (28) - 36525 (33) - 56981 (21) 920 (20) 709 (19) 766 (19) -126 (19) 259 ( 17) -222 (JS) 
C( l9) 417 (30) - 38667 (30) -49791 (22) ll05 (25) 597 (18) 904 (22) - 204 (19) 213 (20) 72 (18) 
C(20) -1017 (26) -28467 (28) -43272 (20) 702 (17) 651 (16) 794 (18) -180 (14) 85 (15) -17 (15) 
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Table 4. Comparison of bond lengths in the hemiketal ring 
Estimated standard deviations in parentheses where given. 
H-O(B) C(B) 
"" / C(A)
/ "" O(A) C(B') 
~ ~ 
Compound* C(A)-O(A) C(A)-O(B) C(A)-C(B) C(A)-C(B') 
Coriose 1 ·452 (11) A 1 ·403 (11) A 1-560 (13) A 1 ·554 (12) A 
ix-D-Tagatose 1·43 l ·42 1-52 1-53 
a-L-Sorbose 1 ·420 (5) 1-415 (5) 1·515(6) 
( - )-Warfarin 1 ·483 (2) 1-385 (2) 1 ·504 (3) 1 ·507 (3) 
* See text for references. 
Table 5. Least-squares planes for coumarin and- phenyl 
rings and deviations of atoms from planes 
Coumarin plane: 2·3806x-0·9458y- 14·4662z= 5·3137 
0(1) 0·007 A C(7) 0·056 A 
0(2) -0·157 C(8) 0·059 
C(2) 0·035 C(9) 0·029 
C(3) -0·065 C(IO) -0·032 
C(4) -0·023 0(4) -0·103 
C(5) - 0·053 C( 11) 0· 192 
C(6) -0-C)()5 C(l2)"' 0·456 
C(l3)* -0·417 
Phenyl plane: 8·3708x-3·6201y+ 7·6722z= -2·3853 
C(l5) -0·012 A C(l8) -0-<Xl9 A 
C(16) 0·003 C(19) 0·000 
C(17) 0·007 C(20) 0·010 
C(lW -0·172 
* These atoms given zero weight. 
(- )-(S)-warfarin and the racemate (Bravic et al., 1973) 
and found them to be in close agreement, the largest 
differences arising in regions involving the hydrogen-
bonding scheme (see Fig. 2). Comparison has also been 
made with a number of other coumarin-containing 
structures (Table 6: the first four entries are of com-
paratively low precision). 
".he phenolic proton has been transferred to 0(3) 
which is hydrogen bonded to 0(2') of the symmetry-
r~lated molecule at -x,y+!,--!--z. The 0(3)-0(2') 
distance is 2·767 (5) A and the O-H-0 angle is 166 (2)°, 
the proton being not quite directed at 0(2'). There are 
no. other intermolecular hydrogen bonds. Along z, 
P~1 rs of molecules related by twofold screw axes pack 
With the coumarin rings nearly parallel. 
!hermal motion of the atoms in the phenyl ring is 
~u1te large, causing appreciable bond shortening, par-
ticularly bonds C( l 7)-C(l8) and C(I 8)-C(l9). The 
average aromatic C~C bond is 1·375 A. Table 7 lists 
the bond lengths and angles in ( - )-warfarin. 
Absolute configuration 
Although there are no atoms heavier than 0, several 
attempts to determine the absolute configuration of 
AC llB-2• 
such compounds have been successful (Engel, 1972; 
Hope & De la Camp, 1972). We felt that such an at-
tempt could be successful in the case of warfarin in 
view of the good level of refinement attained. 
Attempts to prepare crystalline sodium, potassium, 
and cesium salts of ( - )-warfarin all yielded glasses. 
The synthesis of a selectively brominated derivative 
was deemed impractical in view of the time that would 
be required to separate and identify the various prod-
ucts. The most direct approach is to examine the free 
drug itself. 
No enantiomer-sensitive reflections could be found 
in the data used to solve the structure because the 
anomalous scattering of oxygen is vanishingly small 
with Mo Ka radiation. With Cu Ka radiation, how-
ever, the relatively small anomalous scattering of four 
oxygens out of 23 non-hydrogen atoms may be detect-
able. Rather than recollecting a full set of Cu data, 
the best reflections for enantiomer indication were 
chosen from the calculated structure factors including 
anomalous scattering (Lff~=O·Ol9, Af~' = 0·010, .Jf~= 
0·049, Af~ =0·032). The list of reflections was scanned 
for those with the largest differences between the Bij-
voet pairs AFB1,, and a group of 34 reflections was 
chosen, which had AF8 1J/ Fcu greater than 0·006. Since 
these reflections are all relat i.vely weak, it was neces-
sary to improve precision by increasing the scan time. 
An approximate calculation suggested count times of 
320 to 650 s for the largest reflection (taking into ac-
count an estimated count increase of Cu Ka over Mo Krx. 
radiation because of its greater efficiency of scattering). 
The scan speed was reduced to 0· 125° min -r and 
the w/2() scan technique used over a scan range in 28 
of l ·2° plus an amount accounting for the rx.ca2 sepa ra-
tion. Collection times varied from 610 to 800 s. Back-
ground counts of 200 s were collected at each limit of 
the scan range. The eight most intense reflections of 
the 34 chosen were measured in each octant yielding 
four sets of Friedel pairs, while the remaining 26 were 
observed only for their hkl and liki. Data were meas-
ured with the same diffractometer and on the same 
crystal as used for the Mo Ka. data set. The source was 
a fine-focus Cu-target X-ray tube operating at 30 mA 













1·36 A 1·36 A 
1·40 1·30 
l ·41 I ·33 
1·37 1'37 







C(2)-C(3) C(3)-C(4) C(4)-0(4) 
!A2A 1-38 A 1·34 A 
I ·51 l ·30 I ·32 
1·46 1 ·3 l I ·33 
1·44 1 ·35 1-35 
1'43 1·41 l ·34 
3-( 1-Naphthyl)-4-hydroxycoumar in• J-38 I ·36 1·23 1·43 1·37 l ·33 
Phenprocoumonl 1-38 I ·37 1·23 1-42 1·37 I ·34 
Racemic warfarin• l ·38 I ·38 1·21 1·42 1·36 I ·35 
( - )-(S)-Warfarin~ 1-38 1-38 1·22 1-44 1 ·35 l ·35 
Coumarini 1·38 1-37 1·20 1·45 1·34 
Coumarin1 1.'33 l ·37 1·22 1·44 1·34 
(a) Alcock & Hough (1972); (b) Bravic, Gaultier & Hauw (1968); (c) Gaultier & Hauw (1966); (d) Gaultier & Hauw (\965); 
(e) Bra vie, Gaultier, Geoffre & Hauw (1974); (f) Bra vie, Gaultier & Hauw (1971); (g) Bra vie, Gaultier & Hauw ( 1973); (/z) this 
work; (i) Miasnikova, Davydova & Simonov (1973); (j) Gavuzzo, Mazza & Giglio (1974). 
Table 7. Bond lengths (A) and angles(°) 
O(l)-C(2) 1 ·375 (2) C(2)-0( I )-C(9) 121·5 (2) 
O(l)--C(9) I ·378 (3) O(l)--C(2)-C(3) 118·7 (2) 
0(2)--C(2) 1·217 (3) 0( l)--C(2)--0(2) 115·4 (2) 
C(2)-- C(3) 1-439 (3) C(3)- C(2)-0(2) 125'8 (2) 
C(3)--C(4) 1-351 (3) C(2)-- C(3)- -C(4) 119·1 (2) 
C(3)--- C(l l) 1·514 (3) C(2)-C(3)--C(11) 118-4(2) 
C(4)-0(4) 1·351 (2) C(4)-C(3)-C(l l) 122·4 (2) 
C(4)-C(l0) 1-454 (3) C(3)-C(4)-C(l0) 121·5 (2) 
C(9)--C( l0) 1-387 (3) 0( 4 )-- C( 4)-- C(10) 113·8(2) 
C(5)-C(IO) J ·398 (3) 0(4)-- C(4)- -C(3) 124·7 (2) 
C(5)-C(6) 1 ·384 (4) C(4)-0(4)-C(l 3) 115-6 (2) 
C(6)--C(7) 1-380 (4) C(6)-- C(5)- -C( 10) 120·3 (2) 
C(7)--C(8) 1 ·372 (4) C( 5)--C( 6 )-C(7) 119·9 (2) 
C(8)--C(9) 1 ·383 (3) C( 6)-C(7)-C(8) 121 ·0 (2) 
C(l 1)- C(l 2) 1 ·536 (3) C(7 }-- C(8)-C(9) 118·8 (2) 
C(l L)-C(l 5) I ·522 (3} O(l)-C(9}-C(8) 116·9 (2) 
C(l2)-C(l 3) l ·504 (3) 0(1)--C(9)-C(LO) J 2 l ·3 (2) 
C(13)-C(l4) 1-507 (3) C(8)-C(9}-C( l 0) 121·8 (2) 
C(l3)-0(3) 1-385 (3) C(4)-C(IO)-C(5) 124·8 (2) 
C(l 3)-0(4) 1 ·483 (2) C(4)-C(IO)-C(9) 117·0 (2) 
C(l 5)- C(l6) 1·378(3) C(5)-C(IO)-C(9) 118·2 (2) 
C{l 5}- C(20) 1-386 (3) C(3)-C(l 1)-C{l2) 108-3 (2) 
C(l6)-C(l7) 1 ·385 (4) CO)--C(l l)-C(IS) 114·0 (2) 
C(l 7)-C(l 8) I ·356 (5) C(12)-C(l 1)-C(l 5) 108·0 (2) 
C( 18)-C(l 9) l ·359 (4) C(l 1)-C(l 2)-C(13) 112·4 (2) 
C(l9)-C(20) l ·390 (4) 0(3)--C(l 3)-0(4) 108·0 (2) 
0(3 )--H(3 I) 0·93 (2) 0(3 )- C(l 3)- C(12) 108·5 (2) 
0(3)-C(l3)-C(l4) 113·7 (2) 
0(4)--C(l3)- C(l 2) 108·2 (2) 
0(4)--C(l3)-C(I4) 103-9 (2) 
Average C-H lengths: C(l2)-C(l 3)- C(l4) 114·1 (2) 
Coumarin C(ll)-C(l 5)-C(20) 121·9 (2) 
C---H 0·96 C(l 1)-C(l 5)-C(16) 120·4 (2) 
C(20)-C( 15)-C( 16) 117·5 (2) 
Phenyl C(t 5)-C(l6)-C(l 7) 120·8 (3) 
C--H 0·99 C(l6)-C(l 7)-C(l 8) 121 ·0 (3) 
C(I 7)-C( 18)-C( 19) 119-4 (3) 
Aliphatic C(l 8)-C( l 9)-C(20) 120·4(3) 
C--H 0·99 C(l 9)-C(20)-C( 15) 120·9 (2) 
and 40 kV. The cell constants were redetermined with 
Cu KrJ. radiation (A= l ·5418 A), and are: a= 10·883 (2), 
b=9·563 (2) and c= 14·904 (3) A. Reflections 1 through 
8 in the four octants (hkl, nH, hkl,hkl) were collected 
first. Then the Friedel pairs of refkctions 9 through 34 
were collected followed by reflections l through 8 in 
the remaining four octants (hkl,l1kl,hk!,hkl). Friedel 
pairs were observed at + W, x and qJ and then at + 20, 
- x and 180° + q;. 
Data collection required 48 h of essentially con· 
tinuous exposure to the beam. Some crystal deteriora· 
tion was noted during Mo Ka irradiation, and further 
deterioration was expected for the Cu K(I. data. The 
data were collected in the order noted above to aid in 
assessing the effects of deterioration and other possible 
systematic problems. 
Standard deviations in the intensities were calcu-
lated by the formula 
a(I1• 1) = [Npk + (t/tb11)2Nb11 + (0·005 Npk)2Jl12• 
NPk is the peak count, t is the peak scan time, tb11 is 
the background count time, and Nb11 is the background 
count. 
Since the model refined with Mo Ka data was (R, R), 
both asymmetric centers had the same configuration* 
and agreement between inequalities of the Friedel pairs 
predicted and observed with Cu Ka radiation would 
indicate the (R, R) configuration. Of the 34 unique 
Friedel pairs, 28 indicate the opposite of that predicted, 
i.e. 82 % of the reflections indicate the (S, S) configura· 
tion. Including the symmetry-related reflections of 1 
through 8 (all octants), we have 58 Friedel pairs, 45 in-
dicating the (S, S) configuration, a 78 % indication. 
* Warfarin in the open-chain keto form has a single asym-
metric center at C(l l), but the formation of the hemiketal 
introduces a second center at C(l3). The term (R, R) refers to 
the (2R, 4R) configuration and (S, S) refers to the (2S, 4S) con· 
figuration. Note that both centers are constrained to be the 
same. In the racemate (Bravic et al., 1973) the configurations 
then become (2R, 4R) and (2S, 4S). 
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Table 8 summarizes the results, and Table 9 shows the 
indications of the individual reflections, except for I 
through 8 which are averages. 




Unique Friedel pairs, 1- 34° 34 
All octant reflections, 1- 8t 32 
All Friedel pairs 1- 34 and octant 
reflections of 1- 8 58 
Abridged set for R calculalionst 51 
• hkl and hid only. 













t Omits reflections 223, 466, 126, and 5,2,1 1 (see text). 
It is seen that an indication of absolute configura-
tion is evident from the intensity inequalities alone, 
although v.ith less certainty than for structures con-
taining heavy atoms. The high proportion of the data 
indicating the (S, S) configuration ever the other enan-
tiomer is striking in view of the fact that oxygen makes 
up only 20 % of the structure. 
The data set was abridged to exclude reflections with 
uneven background counts and two with Lla(i) values 
much greater than average values. The structure fac-
tors of these reflections were calculated and compared 
with those calculated from the parameters obtained 
from the Mo Ka structure but using the cell constants 
determined with Cu Ka radiation, including both the 
real and imaginary terms of the anomalous scattering 
of oxygen and carbon. After refining the scale factor 
for the observed data, R+ =0·0214* and R_ , obtained 
by inverting the sign of Af" was 0·0182, R.;. / R._ = 1·18 
and S +IS_ t = I· 17. Thus, with fairly high confidence 
we can assign the (S, S) enantiomeric configuration to 
( - )-warfarin on the basis of intensity inequalities and 
R values. 
Our only attempt to refine the anomalous scattering 
factors was to minimize R_ by adjusting the terms 
JJf;;, and Af~. The ratio of A(~ /JJf~ was held constant 
at 3·55 (Hope & De la Camp, 1972) and Af~ was 
varied in the range 0·020 to 0·047 (df~ in the range 
• '+ ' refers to the (R, R) configuration and' - ' lo the (S, S) 
configuration. 
t S ± = 2;((1F.l - IFcl2/o-2(F.)). 
Table 9. Enantiomer-determining refiections 
No. h k L1CT(l)• D!b• 100.dFslJ,• IOOLfF~tJ,c IOOL1F~IJ .~ 
A B 
1 4 2 3 2·8 l·O 8·0 14 22 
2 2 2 3 7·9 e 
3 6 1 I 3·5 0 ·9 8·2 11 .19 
4 3 4 4 2·4 0·6 6·2 Average 11 17 
5 2 2 4 8·2 1-5 11·0 of 4 obscrva- 13 22 
6 6 1 2 3·1 0 ·6 - 7·2 tions -9 -16 
7 5 1 7 l ·7 0·5 4·8 9 15 
8 1 1 9 3·1 0·3 - 6·8 -8 -12 
9 2 3 2 10·7 1·8 -17 -15 - 21 
10 3 5 2 6-S 2·1 - ll - 17 -26 
l I 3 2 11 5·9 0·7 -11 - 13 -20 
l2 1 2 6 28·8 e 
13 4 6 6 0·3 e 
14 5 2 11 24·0 e 
15 9 2 2 3·4 0·5 6 -10 -16 
16 2 1 7 2·3 0·5 3 7 13 
17 9 4 3 7·6 0·3 IS 10 15 
18 5 5 2 3· I 0 ·2 5 -7 - 10 
19 1 7 3 ·8 0·4 -1 -9 -16 
20 7 2 6 5·1 0·3 8 9 15 
21 6 4 2 2·0 0·4 -3 -7 - 12 
22 6 3 3 7·9 0·5 13 9 15 
23 5 2 13 4·0 0·2 7 9 12 
24 7 7 8 11 ·0 O·l 19 9 12 
25 7 4 2 7·4 0 ·3 13 9 15 
26 8 3 6 7·6 0·3 14 7 13 
27 1 5 9 3·4 0·2 - 7 -10 -16 
28 3 2 13 4·8 0·2 10 10 15 
29 3 I 5 7-1 1·4 11 12 21 
30 12 I 4 5·7 0·2 - 10 -10 - 14 
31 4 2 6 10·7 0·4 15 10 14 
32 4 2 11 4·5 0·3 - 18 - 10 -13 
33 2 5 7 10·7 0·9 21 13 21 
34 11 2 2 2·8 0·2 5 9 13 
(a) Llo(l) "" ll•u - /j,r;l/2c(/). (h) Dob• = (Lf Fu1i)' /(o{F))1• (c) L1 F01i.c based on Lff~' = 0·011, Lff(; = 0·037. (cf) Lf F 01; ,c based on &J;; = 
- 0·032 only. (e) Reflections excluded from abridged data set. 
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0·007 Lo 0·014). A minimum of R_ = 0·0181 was 
found for 4f~ = 0·037 and A/;;.= 0·011. Although this 
is only 0·0001 lower than R_ found for L1f~ = 0·032 
and Af~' =0·010 and A/~ =0·049 and A/~ =0·019, the 
enantiomer, R+ = 0·0220, increased by 0·0006, in-
creasing the mtio R+ /R _ to 1·21 and S +/S_ to 1·18, 
in agreement with previous work (Hope & De la 
Camp, 1972) in which Af~ was found to be larger than 
that calculated by Honl's (1933) formula of 0·032. 
Table 9 lists the data on the 34 reflections used in deter-
mining absolute configuration. 
Programs used in refinement and structure-factor 
calculations were part of the X-RAY system (Stewart, 
Kundell & Baldwin, 1970). Molecular diagrams were 
made with program ORTEP, the thermal ellipsoid pro-
gram (Johnson, 1965). We wish to acknowledge the 
financial assistance of the Rubenstein Fellowship of 
the School of Pharmacy and USPHS Grant GM-10828 
from the National Institutes of Health. We thank 
Professor E. C. Lingafelter for many helpful discus-
sions and comments and Mr L. C. Sieker for technical 
assistance. 
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